A significant breakthrough in cancer investigation is emerging with the use of VHH fragments to re-engage mutated p53. This vital tumor inhibitor protein is frequently disabled in various kinds of cancer, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research